ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO)

Launched by IHF GMBH - INSTITUT FÜR HERZINFARKTFORSCHUNG · Apr 6, 2022

Keywords

ClinConnect Summary

The ILUMIEN-V - AERO trial is a clinical study that looks at how a special imaging technique called Optical Coherence Tomography (OCT) is used during heart procedures to help doctors treat patients with heart issues related to reduced blood flow, known as myocardial ischemia. The study aims to understand how this technique is being used in real-life situations and to see how a specific method called the MLD-MAX algorithm affects the treatment of patients undergoing a procedure called Percutaneous Coronary Intervention (PCI).

To participate in this trial, patients should be at least 18 years old and have signs of myocardial ischemia, which can include conditions like stable angina (chest pain), unstable angina, or a heart attack. Participants will need to give their written consent to take part in the study. There are no specific exclusions, meaning almost anyone with the relevant heart condition can join. If you decide to participate, you can expect to have your heart condition evaluated using the OCT technique, which helps doctors see what’s happening in your blood vessels and decide on the best treatment options for you.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Patients with evidence of myocardial ischemia (e.g. stable angi-na, silent ischemia, unstable angina, or acute myocardial infarc-tion) undergoing OCT-guided lesion evaluation (OCT-scan using the devices must be performed either to guide PCI (following the MLD-MAX-algorithm) or to investigate a coronary lesion for fur-ther clinical treatment)
• • Written informed consent (defined as legally effective, docu-mented confirmation of a subject's (or their legally authorized representative or guardian) voluntary agreement to participate in a particular clinical study) to participate in this clinical inves-tigation
• Exclusion Criteria:
• • none